BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR
    1.
    发明申请
    BORRELIA IMMUNOASSAYS AND MATERIALS THEREFOR 审中-公开
    BORRELIA免疫测定仪及其材料

    公开(公告)号:WO2017062535A3

    公开(公告)日:2017-05-26

    申请号:PCT/US2016055618

    申请日:2016-10-06

    CPC classification number: G01N33/56911 C07K14/20 G01N2333/20

    Abstract: The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.

    Abstract translation: 本发明涉及用于检测疑似莱姆病感染的生物样品中疏螺旋体属特异性IgG,IgM和IgG / IgM抗体的免疫测定法。 免疫测定可以通过标准的免疫测定方式或在自动化平台上进行。 在各种实施方案中,免疫测定法单独或与一种或多种疏螺旋体特异性嵌合肽VlsE-FlaB(命名为pFlaB-mV),VlsE-ErpP(命名为pErp59-mV),VlsE-P35(命名为pP35-mV) 更多外表面蛋白C(Osp C)B或I型,p58和DbpA。 本发明的其它方面提供了包含用于本文所述的免疫测定中的公开的肽和/或蛋白质的组合的抗原/底物组合和组合物。

Patent Agency Ranking